Targeted-release budesonide therapy for IgA nephropathy

Lancet. 2017 Dec 16;390(10113):2625. doi: 10.1016/S0140-6736(17)32145-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Budesonide*
  • Glomerulonephritis, IGA*
  • Humans

Substances

  • Budesonide